A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

Launched by CHANNEL MEDSYSTEMS · Jun 19, 2023

Keywords

ClinConnect Summary

This clinical trial, called the Progress registry, is focused on gathering real-world data about the Cerene® Cryotherapy Device, which is used to treat conditions like heavy menstrual bleeding and abnormal uterine bleeding. The goal is to understand how well the device works in everyday settings, compared to its performance in earlier studies. The trial is currently recruiting women aged 25 and older who are scheduled to receive this treatment and can speak English. Participants must agree to complete surveys at different points over the course of a year to help the researchers collect valuable information.

If you decide to join this registry, you will be contributing to important research that could improve future treatments for women experiencing these bleeding issues. You'll need to provide your consent to participate, and there may be some patients who are not eligible based on their doctor's recommendations or other specific factors. Your participation will help bridge the gap between clinical trial results and what happens in real life, potentially benefiting many women in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Scheduled for a Cerene treatment
• • 25 years of age and older
• • Provided informed consent to participate in the registry
• • English speaking
• • Agrees to complete a survey at specified time points from baseline to 12 Months
• Exclusion Criteria:
• • Physician discretion
• • Vulnerable populations